A case of Henoch‐Schonlein purpura presenting with pulmonary involvement
DOI:
https://doi.org/10.18203/2349-3933.ijam20210609Keywords:
Henoch schonlein purpura, Methotrexate toxicity, SteroidsAbstract
Pulmonary involvement in Henoch‐Schonlein purpura (HSP) although rare is an important treatable cause of hospital admission in patients. Its diagnosis is difficult due to the vague symptoms and non-specific radiographic findings. We present one such case of a known case of HSP presenting with pulmonary involvement and treated successfully with steroids and immunosuppressant medications after ruling out all other causes. This particular case could also have an additional component of methotrexate induced lung involvement. Overall it is an interesting case with some much needed learning points.
References
Nadrous HF, Yu AC, Specks U, Ryu JH. Pulmonary. Henoch-Schönlein Purpura. Mayo Clinic Proceedings. 2015;79(9):1151-7.
Setji N, Norton D. Rare Pulmonary Manifestations of Henoch‐Schonlein Purpura in an Adult. Abstract published at Hospital Medicine. 2014;24-7.
Jakubovic BD, Donovan A, Webster PM, Shear NH. Methotrexate-induced pulmonary toxicity. Can Respir J. 2013;20(3):153-5.
Cubero CC, Carmona C. Diffuse Alveolar Hemorrhage as an Initial Manifestation of Henoch-Schönlein Purpura in Adults. Int J Respir Pulm Med. 2012;3:052.
Sim YS. A case of pulmonary hemorrhage associated with Henoch-Schönlein purpura, Tuberc Respir Dis. 2009;67:226-8.
Pilar. Ann Rheumat Diseas. 1994;53:434-9.
Arakawa H, Yamasaki M, Kurihara Y, Yamada H, Nakajima Y. Methotrexate-induced pulmonary injury: serial CT findings. J Thorac Imag. 2003;18(4):231-6.
